Proper Name: Pneumococcal 20-valent Conjugate Vaccine
Tradename: PREVNAR 20
Manufacturer: Wyeth Pharmaceuticals, LLC
Indication: Active immunization for the prevention of pneumonia and invasive disease caused by Streptococcus pneumoniae serotypes 1, 3, 4, 5, 6A, 6B, 7F, 8, 9V, 10A, 11A, 12F,14, 15B, 18C, 19A, 19F, 22F, 23F and 33F in adults 18 years of age and older.
- Package Insert - PREVNAR 20
- Demographic Subgroup Information - PREVNAR 20 (Pneumococcal 20-valent Conjugate Vaccine)
Refer to Section 1.1 of the Clinical Review Memo for information about participation in the clinical trials and any analysis of demographic subgroup outcomes that is notable.